Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”

The coronavirus disease 2019 (COVID-19) pandemic has become a global burden, further exacerbating the occurrence of risk events in cancer patients. The high risk of death from pancreatic cancer makes it one of the most lethal malignancies. Recently, it was reported in the World Journal of Gastrointe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jian, Liu, Ying, Liu, Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994044/
https://www.ncbi.nlm.nih.gov/pubmed/36908318
http://dx.doi.org/10.4251/wjgo.v15.i2.368
_version_ 1784902599576649728
author Yang, Jian
Liu, Ying
Liu, Shi
author_facet Yang, Jian
Liu, Ying
Liu, Shi
author_sort Yang, Jian
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic has become a global burden, further exacerbating the occurrence of risk events in cancer patients. The high risk of death from pancreatic cancer makes it one of the most lethal malignancies. Recently, it was reported in the World Journal of Gastrointestinal Oncology that COVID-19 influences pancreatic cancer progression via the lung–gut–pancreatic axis, and the authors provided insights into the intrinsic crosstalk mechanisms in which the gut microbiota is involved, the characteristics and effects of inflammatory factors, and immunotherapeutic strategies for treating both diseases. Here, we review the latest cutting-edge researches in the field of the lung-gut-pancreatic axis and discuss future perspectives to address the severe survival challenges posed by the COVID-19 pandemic in patients with pancreatic cancer.
format Online
Article
Text
id pubmed-9994044
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-99940442023-03-09 Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression” Yang, Jian Liu, Ying Liu, Shi World J Gastrointest Oncol Letter to the Editor The coronavirus disease 2019 (COVID-19) pandemic has become a global burden, further exacerbating the occurrence of risk events in cancer patients. The high risk of death from pancreatic cancer makes it one of the most lethal malignancies. Recently, it was reported in the World Journal of Gastrointestinal Oncology that COVID-19 influences pancreatic cancer progression via the lung–gut–pancreatic axis, and the authors provided insights into the intrinsic crosstalk mechanisms in which the gut microbiota is involved, the characteristics and effects of inflammatory factors, and immunotherapeutic strategies for treating both diseases. Here, we review the latest cutting-edge researches in the field of the lung-gut-pancreatic axis and discuss future perspectives to address the severe survival challenges posed by the COVID-19 pandemic in patients with pancreatic cancer. Baishideng Publishing Group Inc 2023-02-15 2023-02-15 /pmc/articles/PMC9994044/ /pubmed/36908318 http://dx.doi.org/10.4251/wjgo.v15.i2.368 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Letter to the Editor
Yang, Jian
Liu, Ying
Liu, Shi
Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”
title Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”
title_full Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”
title_fullStr Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”
title_full_unstemmed Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”
title_short Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”
title_sort comment on “crosstalk between gut microbiota and covid-19 impacts pancreatic cancer progression”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994044/
https://www.ncbi.nlm.nih.gov/pubmed/36908318
http://dx.doi.org/10.4251/wjgo.v15.i2.368
work_keys_str_mv AT yangjian commentoncrosstalkbetweengutmicrobiotaandcovid19impactspancreaticcancerprogression
AT liuying commentoncrosstalkbetweengutmicrobiotaandcovid19impactspancreaticcancerprogression
AT liushi commentoncrosstalkbetweengutmicrobiotaandcovid19impactspancreaticcancerprogression

Ejemplares similares